Month: July 2021

BOULDER, Colo., July 19, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (Nasdaq: BBI) (“Brickell” or the “Company”), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 8,064,517 shares of common stock of the Company at a price to the public of $0.62 per share, less underwriting discounts and commissions. The closing of the public offering is expected to occur on or about July 22, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company...

MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devices that target the underlying causes of the world’s most prevalent eye diseases, today announced the closing of its initial public offering of 11,500,000 shares of common stock including the exercise in full of the underwriters’ option to purchase 1,500,000 additional shares of common stock, at the initial public offering price of $24.00 per share. The total gross proceeds to Sight Sciences, before deducting underwriting discounts and commissions and offering expenses, were approximately $276 million. Shares of Sight Sciences’s common stock began trading on the Nasdaq Global Market on July 15, 2021, under the ticker symbol “SGHT.” Morgan Stanley and...

FRANKLIN, Ind., July 19, 2021 (GLOBE NEWSWIRE) — IBC Advanced Alloys (TSX-V: IB; OTCQB: IAALF) (“IBC” or the “Company”), a leading beryllium and copper advanced alloys company, was pleased to host U.S. Congressman Trey Hollingsworth (R-9th-Ind.) on a recent tour of IBC’s expansion and consolidation project now underway at its copper alloys plant in Franklin, Ind. Rep. Hollingsworth, who represents Franklin in the U.S. Congress, has been very supportive of IBC and the Franklin plant, where workers manufacture a variety of copper-based alloy components for use in commercial and defense industries. Front-page news media coverage of the Congressman’s visit in the Franklin Daily Journal can be seen here. “This is such great news to see, you know, the excitement here, the energy here, and obviously the continued investment...

THE WOODLANDS, Texas, July 19, 2021 (GLOBE NEWSWIRE) — Smart Sand, Inc. (NASDAQ: SND) (the “Company”) announced today that it will release its second quarter financial results after the market closes on Tuesday, August 3, 2021. The Company will hold a conference call for investors on Wednesday, August 4, 2021 at 10:00 a.m. Eastern Time to discuss recent events and the results. Chuck Young, the Company’s chief executive officer, Lee Beckelman, the Company’s chief financial officer and John Young, the Company’s chief operating officer, will host the call. Investors are invited to listen to a live webcast of the conference call by visiting the “Investors” section of the Company’s website at www.smartsand.com. The call can also be accessed live over the telephone by dialing (888) 799-5165 or for international callers, (478) 219-0056....

— Shelf space for all three SKUs of VAZALORE is being reserved with ‘Coming Soon’ shelf placeholders —VAZALOREPLx Pharma Inc.’s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August.SPARTA, N.J., July 19, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products, with its lead products VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”), today announced that three stock-keeping units (“SKUs”) of VAZALORE, the first and only U.S. Food and Drug Administration (“FDA”) approved liquid-filled aspirin capsules, will be available in over 8,000 Walgreens stores nationwide later...

Achieving lower loss and power consumption while improving cost performanceROHM’s new RGWxx65C series of hybrid IGBTs with an integrated 650V SiC Schottky barrier diodeRGWxx65C Series Loss Comparison ChartSanta Clara, CA and Kyoto, Japan, July 19, 2021 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced the RGWxx65C series of hybrid IGBTs with an integrated 650V SiC Schottky barrier diode. The devices, qualified under the AEC-Q101 automotive reliability standard, are ideal for automotive and industrial applications that handle high power, such as photovoltaic power conditioners, onboard chargers, and DC/DC converters used in electric and electrified vehicles (xEVs). The RGWxx65C series (RGW60TS65CHR, RGW80TS65CHR, RGW00TS65CHR) utilizes ROHM’s low-loss SiC Schottky barrier diodes in the...

PARIS and CAMBRIDGE, Mass., July 19, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces that the judge in charge of overseeing judgements execution has rendered on July 16, 2021 a judgement in the proceedings between Biophytis and Negma Group Ltd. (“Negma”). Following the judgment rendered by the Paris Commercial Court on March 16, 2021 (see the press release dated March 19, 2021 available on the Company’s website) in the proceedings on the merits between Biophytis...

HOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID # 6293853. The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, go to http://investor.harvardbioscience.com/ – Events & Presentations. Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations...